15/06/2022
Our AI based Market research for insulin in the US market revealed some interesting insights. Here’s a sneak-peak on what is driving HCPs in prescribing insulin drugs.
60% HCPs - Consider Early onset of Microvascular complications
56% HCPs – Consider weight fluctuation of more than 11 pounds
46% HCPs – Consider insurance and patient's ability to bear the treatment cost
These insights are just the tip of an iceberg, would you like to know more?
Watch a quick video - https://bit.ly/39qqokl